Feature | August 21, 2012

New Competence Center Promotes Safe, Efficient Use of RT Dosimetry

High-quality dosimetry training is available to the international radiotherapy community at the new ICC in Germany

Training at the new International Competence Center.

August 21, 2012 — IBA (Ion Beam Applications S.A.) officially opened its International Competence Center (ICC) in July in Nuremberg, Germany. The ICC provides high-level practical training to promote safer radiation therapy to healthcare professionals, using the latest software and hardware radiation treatment and specialist measurement tools.

Exceptional accuracy and reliability is necessary to deliver safe and effective radiation treatment. Recent developments to radiation delivery platforms and other new technologies have allowed greater control of radiation dose distribution and the delivery of a higher, more targeted, radiation dose to tumors. However, as technology becomes more complex, the risk of errors and the adverse effects of radiation also increase.

Dosimetry training at the ICC will provide healthcare professionals with essential knowledge and skills necessary to minimize radiation errors and maximize accuracy and efficiency in their daily checks, contributing to significantly reducing treatment downtime.

“The idea behind the establishment of the ICC is to improve cancer treatment outcomes by providing high-quality dosimetry training to healthcare professionals involved in the planning and delivery of radiation therapy," said Rob Plompen, president of IBA Dosimetry. "With the ICC, we have created an environment that promotes an international exchange of knowledge and experiences among those involved in measuring radiation dosage. Our comprehensive training courses will include topics such as efficient and effective linear accelerator (linac) and RTPS commissioning, verifying complex intensity-modulated radiation therapy (IMRT) and rotational treatments in 2-D and 3-D, and regulatory and quality assurance matters in radiation therapy.”

For more information: www.iba-group.com

Related Content

For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Getty Images

News | Prostate Cancer | December 02, 2020
December 2, 2020 — ...
During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.

Getty Images

News | Prostate Cancer | November 18, 2020
November 18, 2020 — ...
Minimizing delays to treatment could improve cancer survival rates, say researchers

Getty Images

News | Radiation Oncology | November 10, 2020
November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% high
In this retrospective cohort study of men with low-risk prostate cancer followed up for a median of 7.6 years, African American men, compared with non-Hispanic White men, had a statistically significant increased 10-year cumulative incidence of disease progression and definitive treatment, but not metastasis or prostate cancer–specific mortality

Getty Images

News | Prostate Cancer | November 04, 2020
November 4, 2020 — Previous studies have shown that African American men are 2.4 times as likely to die from...